scholarly journals Normal pregnancy in a patient with β-thalassaemia major receiving iron chelation therapy with deferasirox (Exjade®)

2011 ◽  
Vol 86 (3) ◽  
pp. 274-275 ◽  
Author(s):  
Dimitra Vini ◽  
Philippos Servos ◽  
Marouso Drosou
Keyword(s):  
Chelation Therapy ◽  
Iron Chelation ◽  
Normal Pregnancy ◽  
Iron Chelation Therapy ◽  
Thalassaemia Major

Effect of enhanced iron chelation therapy on glucose metabolism in patients with β-thalassaemia major

2006 ◽  
Vol 134 (4) ◽  
pp. 438-444 ◽  
Author(s):  
Kalistheni Farmaki ◽  
Nicholas Angelopoulos ◽  
George Anagnostopoulos ◽  
Efstathios Gotsis ◽  
Grigorios Rombopoulos ◽  
...  
Keyword(s):  
Glucose Metabolism ◽  
Chelation Therapy ◽  
Iron Chelation ◽  
Iron Chelation Therapy ◽  
Thalassaemia Major

Endocrinopathies in adolescents with thalassaemia major receiving oral iron chelation therapy

2014 ◽  
Vol 36 (1) ◽  
pp. 22-27 ◽  
Author(s):  
Rajni Sharma ◽  
Anju Seth ◽  
Jagdish Chandra ◽  
Suraj Gohain ◽  
Seema Kapoor ◽  
...  
Keyword(s):  
Chelation Therapy ◽  
Iron Chelation ◽  
Oral Iron ◽  
Iron Chelation Therapy ◽  
Thalassaemia Major

Cardiac iron measurement and iron chelation therapy in patients with β thalassaemia major: experience from Taiwan

2013 ◽  
Vol 23 (2) ◽  
pp. 100-107 ◽  
Author(s):  
M. -Y. Lu ◽  
S. S. F. Peng ◽  
H. -H. Chang ◽  
Y. -L. Yang ◽  
C. -A. Chen ◽  
...  
Keyword(s):  
Chelation Therapy ◽  
Iron Chelation ◽  
Iron Chelation Therapy ◽  
Thalassaemia Major ◽  
Cardiac Iron

Iron Chelation Therapy in CAPD: A New and Effective Treatment of Iron Overload Disease in Esrd Patients

1983 ◽  
Vol 3 (2) ◽  
pp. 99-101 ◽  
Author(s):  
Glen H Stanbaugh ◽  
A. W, Holmes Diane Gillit ◽  
George W. Reichel ◽  
Mark Stranz
Keyword(s):  
Peritoneal Dialysis ◽  
Iron Overload ◽  
End Stage Renal Disease ◽  
Chelation Therapy ◽  
Iron Chelation ◽  
Iron Chelation Therapy ◽  
Peritoneal Dialysate ◽  
Stage Renal Disease ◽  
End Stage ◽  
Esrd Patients

A patient with end-stage renal disease on CAPD, and with massive iron overload is reported. This patient had evidence of myocardial and hepatic damage probably as a result of iron overload. Treatment with desferoxamine resulted in removal of iron in the peritoneal dialysate. On the basis of preliminary studies in this patient it would appear that removal of iron by peritoneal dialysis in conjunction with chelation therapy is safe and effective. This finding should have wide-ranging signficance for patients with ESRD.

Overview of Iron Chelation Therapy with Desferrioxamine and Deferiprone

Hemoglobin ◽  
2009 ◽  
Vol 33 (sup1) ◽  
pp. S58-S69 ◽  
Author(s):  
Maria D. Cappellini ◽  
Khaled M. Musallam ◽  
Ali T. Taher
Keyword(s):  
Chelation Therapy ◽  
Iron Chelation ◽  
Iron Chelation Therapy

THE MANAGEMENT OF IRON CHELATION THERAPY

2008 ◽  
Vol 54 (4) ◽  
pp. 503-507
Author(s):  
M. J. Pippard ◽  
S. T. Callender
Keyword(s):  
Chelation Therapy ◽  
Iron Chelation ◽  
Iron Chelation Therapy

Iron chelation therapy to prevent the manifestations of aceruloplasminemia

Neurology ◽  
2015 ◽  
Vol 85 (12) ◽  
pp. 1085-1086 ◽  
Author(s):  
Francesco Bove ◽  
Alfonso Fasano
Keyword(s):  
Chelation Therapy ◽  
Iron Chelation ◽  
Iron Chelation Therapy
Sign in / Sign up

Export Citation Format

Share Document